Recent released documents show that FDA experts determined seven child deaths were possibly or probably caused by COVID-19 vaccination, a figure revised downward from an initial assessment of 10 cases.

According to the files, two of the deaths — boys aged 13 and 7 — involved heart inflammation (myocarditis) that FDA reviewers concluded was probably linked to the shots. All seven cases underwent autopsies, with the majority involving Pfizer vaccines.

The revelations come from post-marketing safety reviews covering adverse event reports. While officials previously highlighted a higher number internally, the finalized assessment settled on these seven pediatric cases with possible or probable causation.

This disclosure adds to the growing body of post-pandemic scrutiny regarding vaccine safety signals in younger populations — an area that has often been downplayed or met with hesitation in public discussion.

As more internal documents surface under the current administration’s push for transparency, questions lingers in the minds of many families and observers: when will the pharmaceutical companies that developed and promoted these vaccines provide a full, detailed accounting for these outcomes?, what about former health officials who knew about those findings?, and what about the roles of MSM and journalist who never questioned the official narrative?